FDA Inspection 1178819 — Catalent Indiana, LLC

Catalent Indiana, LLC — FEI 3005949964

The FDA completed an inspection of Catalent Indiana, LLC on September 1, 2022 in Bloomington, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 1, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bloomington, IN (United States)